The results suggested that, in 17 cancer types, the mortality risks were significantly elevated in the individuals in the group with high HPRT1 expression in comparison to those with low HPRT1 expression (Supplementary Fig. 8B and Supplementary Table 6). Here, HPRT1 is linked to cancer.